Altimmune, Inc. is a company headquartered in the United States.
Altimmune is a clinical stage biotechnology company developing next-generation vaccines using two complementary vaccine delivery platforms to address public health and biodefense needs including respiratory diseases, chronic infections, and cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.